Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation.

Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.
American Journal of Transplantation (Impact Factor: 6.19). 02/2012; 12(2):428-37. DOI: 10.1111/j.1600-6143.2011.03788.x
Source: PubMed

ABSTRACT Donor livers are precious resources and it is, therefore, ethically imperative that we employ optimally sensitive and specific transplant selection criteria. Current selection criteria, the Milan criteria, for liver transplant candidates with hepatocellular carcinoma (HCC) are primarily based on radiographic characteristics of the tumor. Although the Milan criteria result in reasonably high survival and low-recurrence rates, they do not assess an individual patient's tumor biology and recurrence risk. Consequently, it is difficult to predict on an individual basis the risk for recurrent disease. To address this, we employed microarray profiling of microRNA (miRNA) expression from formalin fixed paraffin embedded tissues to define a biomarker that distinguishes between patients with and without HCC recurrence after liver transplant. In our cohort of 64 patients, this biomarker outperforms the Milan criteria in that it identifies patients outside of Milan who did not have recurrent disease and patients within Milan who had recurrence. We also describe a method to account for multifocal tumors in biomarker signature discovery.

  • [Show abstract] [Hide abstract]
    ABSTRACT: AIM: It is reasonable to investigate non-tumor liver tissues to predict a risk for development of hepatocellular carcinoma (HCC). A molecular analysis of chronically damaged liver tissues may identify specific microRNA (miRNA)-expression profiles associated with a risk for multicentric (MC) HCC. METHODS: Twenty HCC patients, who underwent a curative hepatectomy were classified into two groups; a non-MC group (no MC recurrence in more than 3 years, n=10) and a MC group (MC recurrence within 3 years after hepatectomy, n=10). A miRNA microarray (955 probes) was used to compare the miRNA-expression patterns of the non-cancerous liver tissues between the two groups. This study identified the differentially expressed miRNAs related to MC recurrence in the liver remnant. RESULTS: No differences were observed between the two groups in the liver function tests and pathological variables including both tumor factors and non-tumor liver tissues. The investigation selected 20 differentially expressed miRNAs related to MC recurrence. Eighteen miRNAs were down-regulated, while 2 miRNAs were up-regulated in the MC group. A hierarchical clustering analysis identified a cluster that might be associated with risk of the MC recurrence of HCC. The MC recurrence-related miRNA included let-7d*, miR-328, and miR18a*, which potentially regulate K-ras gene expression. A significant inverse correlation between the miR-18a* expression and the K-ras mRNA expression was confirmed by quantitative reverse transcription-polymerase chain reaction. CONCLUSIONS: Specific miRNA-expression signatures in non-cancerous liver tissue may help to predict the risk for de novo development of HCC.
    Hepatology Research 05/2013; · 2.07 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Since their discovery more than a decade ago microRNAs have been demonstrated to have profound effects on almost every aspect of biology. Numerous studies in recent years have shown that microRNAs have important roles in development and in the etiology and progression of disease. This review is focused on microRNAs and the roles they play in liver development, regeneration and liver disease; particularly chronic liver diseases such as alcoholic liver disease, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, viral hepatitis and primary liver cancer. The key microRNAs identified in liver development and chronic liver disease will be discussed together with, where possible, the target messenger RNAs that these microRNAs regulate to profoundly alter these processes.
    The international journal of biochemistry & cell biology 04/2014; · 4.89 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Liver transplantation has become an established treatment for cirrhotic patients with hepatocellular carcinoma (HCC), and the Milan criteria are now widely accepted and applied as an indication for deceased donor liver transplantation (DDLT) in Western countries. In contrast, however, due to the severe organ shortage, living donor liver transplantation (LDLT) is mainstream in Japan and in other Asian countries.
    Liver cancer. 05/2014; 3(2):108-118.

Full-text (2 Sources)

Available from
Jul 30, 2014